Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Launches US Sales Team

Premium

Rosetta Genomics this week announced that it has established a US sales team that will handle the commercialization of its suite of microRNA-based diagnostics.

The team will particularly focus on Rosetta's miRview Mets and miRview Mets 2 tests, which are designed to determine the source of cancers of unknown primary origin.

Rosetta did not specify the size of the team, but said it will expand it “over the coming quarters.”

The move has long been expected after a dispute between Rosetta and its one-time US distribution partner Prometheus Laboratories resulted in the miRNA company regaining the market rights to its products (GSN 12/2/2010). Rosetta continues to sell its products through distributors outside of the US.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.